Testing new radiotherapy outcomes after low-grade brain tumor surgery
Part of Cancer clinical trials.
This trial studies how patients with grade 2 or 3 low-grade brain gliomas do after modern radiotherapy following surgery (or biopsy). It looks at both brain/memory functioning and cancer outcomes, especially for people at higher risk from their surgery or age.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an infiltrative low-grade glioma (grade 2 or 3) confirmed by pathology from surgery or biopsy
- You have already had a craniotomy with tumor removal or a biopsy, and your care team recommends radiation because of higher-risk features (like incomplete removal or older age)
- Your ability to do daily activities is fairly good (ECOG 0–2 or KPS 70 or higher)
- Your diagnosis is not grade 4 glioma (glioblastoma) and not grade 1 disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a type of very targeted radiation given before surgery for people with a high-grade (aggressive) brain tumor. The goal is to see if this approach is safe and potentially improves treatment, while collecting tumor and blood samples for research.
This trial compares standard radiation therapy versus radiation plus a chemotherapy medicine called temozolomide in people with a newly diagnosed low-grade (WHO grade II) brain glioma after surgery. It’s designed to see if adding temozolomide improves outcomes while managing side effects.
This trial tests a type of radiation therapy that adjusts each day's treatment based on new MRI images taken between sessions. It is for people with high-grade glioma who are receiving the standard chemotherapy and radiation plan.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
This Phase 2 study tests a personalized, computer-guided way to plan proton beam radiation for adults with low-grade glioma. The goal is to see if the approach is feasible and can improve how treatment is planned.
This trial tests putting radiation directly into the brain right after surgery for glioblastoma, instead of waiting for standard radiation later. It aims to see if this approach works better and is safe for you.
Hear when a new Glioma of Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.